Last reviewed · How we verify

NCT05507268

Predictive Nomogram for Postoperative Acute Kidney Injury in Older Patients Undergoing Noncardiac Surgery

Status unknown Last updated 18 August 2022
What this trial tests

trial testing no intervention in Postoperative Acute Kidney Injury in 50,000 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorChinese PLA General Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50,000
Start date1 April 2022
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

Adults 65 to 120, any sex, with Postoperative Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative acute kidney injury is associated increased risk of morbidity and mortality. Older patients are at high risk of developing postoperative acute kidney injury. However, the incidence and associations of postoperative acute kidney injury in older patients are not well understood. This study aims to develop and validate a predictive nomogram for postoperative acute kidney injury in older patients undergoing noncardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Postoperative Acute Kidney Injury

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05507268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing